Engineers Gate Manager LP Immunity Bio, Inc. Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.29 - $3.1 $17,585 - $42,259	13,632 New	13,632 $23,000
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $54,382 - $124,592	-20,292 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.05 - $7.53 $84,198 - $125,547	-16,673 Reduced 45.1%	20,292 $114,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $209,591 - $376,303	36,965 New	36,965 $225,000
Q3 2021 Nov 15, 2021	SELL	$9.17 - $14.24 $804,621 - $1.25 Million	-87,745 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $749,793 - $1.25 Million	55,913 Added 175.65%	87,745 $1.25 Million
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $408,404 - $1.34 Million	31,832 New	31,832 $756,000

212

70.1M

1.64M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.35B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.